AR038350A1 - Carnitina en el tratamiento de la depresion geriatrica - Google Patents
Carnitina en el tratamiento de la depresion geriatricaInfo
- Publication number
- AR038350A1 AR038350A1 ARP030100356A ARP030100356A AR038350A1 AR 038350 A1 AR038350 A1 AR 038350A1 AR P030100356 A ARP030100356 A AR P030100356A AR P030100356 A ARP030100356 A AR P030100356A AR 038350 A1 AR038350 A1 AR 038350A1
- Authority
- AR
- Argentina
- Prior art keywords
- carnitine
- treatment
- geriatric depression
- depression
- alkanoyl
- Prior art date
Links
- 229960004203 carnitine Drugs 0.000 title abstract 3
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 title 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 abstract 3
- RDHQFKQIGNGIED-MRVPVSSYSA-N O-acetyl-L-carnitine Chemical compound CC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C RDHQFKQIGNGIED-MRVPVSSYSA-N 0.000 abstract 1
- -1 alkanoyl L-carnitine Chemical compound 0.000 abstract 1
- 239000000935 antidepressant agent Substances 0.000 abstract 1
- 229940005513 antidepressants Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35432302P | 2002-02-07 | 2002-02-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR038350A1 true AR038350A1 (es) | 2005-01-12 |
Family
ID=27734357
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP030100356A AR038350A1 (es) | 2002-02-07 | 2003-02-05 | Carnitina en el tratamiento de la depresion geriatrica |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20040009926A1 (enExample) |
| EP (1) | EP1471904A1 (enExample) |
| JP (1) | JP2005523269A (enExample) |
| KR (1) | KR20040083471A (enExample) |
| AR (1) | AR038350A1 (enExample) |
| AU (1) | AU2003219511A1 (enExample) |
| CA (1) | CA2469925A1 (enExample) |
| MX (1) | MXPA04007506A (enExample) |
| PL (1) | PL374082A1 (enExample) |
| WO (1) | WO2003066041A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050272812A1 (en) * | 2002-02-07 | 2005-12-08 | Pettegrew Jay W | Methor for use of acetyl-L-carnitine (ALCAR) for treatment of depressive disorders in humans |
| US7407778B2 (en) | 2002-02-07 | 2008-08-05 | Pettegrew Jay W | Compounds, compositions and methods for treating neuropsychiatric disorders |
| US7700074B2 (en) | 2002-02-07 | 2010-04-20 | Pettegrew Jay W | Method and system for diagnosis of neuropsychiatric disorders including chronic alcoholism |
| US7815894B2 (en) | 2003-05-29 | 2010-10-19 | Jay W. Pettegrew | Compounds, compositions and methods for medical imaging of neuropsychiatric disorders |
| EP2582368B1 (en) | 2010-06-16 | 2018-05-09 | Alfasigma S.p.A. | Acetyl-carnitine for use in a method for increasing neurogenesis in neural tissue |
| US11135181B2 (en) | 2014-10-28 | 2021-10-05 | Medlab Ip Pty Ltd | Treatment for depression and depressive disorders |
| US11918336B2 (en) * | 2019-02-19 | 2024-03-05 | King Abdullah University Of Science And Technology | Reduced feature generation for signal classification based on position weight matrix |
| KR20230011999A (ko) | 2020-05-15 | 2023-01-25 | 알파시그마 에스.피.에이. | 메틸폴레이트를 포함하는 조성물 |
| WO2023084531A1 (en) * | 2021-11-12 | 2023-05-19 | Celagenex Research (India) Pvt. Ltd. | A synergistic composition for activating intracellular secondary messenger(camp) pathway |
| CN117797134A (zh) * | 2022-09-23 | 2024-04-02 | 合肥瀚微生物科技有限公司 | 一种4-tmap治疗或缓解抑郁症的用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4346107A (en) * | 1979-02-12 | 1982-08-24 | Claudio Cavazza | Pharmaceutical composition comprising acyl-carnitine for the treatment of impaired cerebral metabolism |
| US5208037A (en) * | 1991-04-22 | 1993-05-04 | Alza Corporation | Dosage forms comprising polymers comprising different molecular weights |
| US5879884A (en) * | 1994-12-29 | 1999-03-09 | Peroutka; Stephen J. | Diagnosis of depression by linkage of a polymorphic marker to a segment of chromosome 19P13 bordered by D19S247 and D19S394 |
| JP3425276B2 (ja) * | 1995-08-11 | 2003-07-14 | 株式会社日立製作所 | 情報通知システム |
| JPH10143640A (ja) * | 1996-11-15 | 1998-05-29 | Nippon Lsi Card Kk | 携帯コンピュータ及びそれを用いた情報管理システム並びにそれを用いた立体地図の作成方法 |
| US5889055A (en) * | 1997-04-04 | 1999-03-30 | Howard; James R. | L-carnitine and acetyl-L-carnitine combined for prevention and treatment of syndromes related to diseases of energy metabolism |
-
2003
- 2003-01-23 KR KR10-2004-7009147A patent/KR20040083471A/ko not_active Ceased
- 2003-01-23 JP JP2003565465A patent/JP2005523269A/ja active Pending
- 2003-01-23 AU AU2003219511A patent/AU2003219511A1/en not_active Abandoned
- 2003-01-23 PL PL03374082A patent/PL374082A1/xx unknown
- 2003-01-23 CA CA002469925A patent/CA2469925A1/en not_active Abandoned
- 2003-01-23 MX MXPA04007506A patent/MXPA04007506A/es unknown
- 2003-01-23 WO PCT/IT2003/000023 patent/WO2003066041A1/en not_active Ceased
- 2003-01-23 EP EP03715324A patent/EP1471904A1/en not_active Withdrawn
- 2003-02-05 AR ARP030100356A patent/AR038350A1/es unknown
- 2003-02-07 US US10/359,560 patent/US20040009926A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20040009926A1 (en) | 2004-01-15 |
| KR20040083471A (ko) | 2004-10-02 |
| JP2005523269A (ja) | 2005-08-04 |
| CA2469925A1 (en) | 2003-08-14 |
| MXPA04007506A (es) | 2004-11-10 |
| WO2003066041A1 (en) | 2003-08-14 |
| PL374082A1 (en) | 2005-09-19 |
| AU2003219511A1 (en) | 2003-09-02 |
| EP1471904A1 (en) | 2004-11-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9700538A (es) | Uso de droloxifeno y sus sales farmaceuticamente aceptables en la preparacion de remedios para las enfermedades cardiovasculares. | |
| CO6331425A2 (es) | Composiciones que comprenden n-(3,4-difluoro-2-(2-fluoro-4-yodofenilamino)6-metoxifenil)-1-(2,3-dihidroxiproxipropil)ciclopropan-1-sulfamida | |
| ECSP066516A (es) | Formulaciones farmacéuticas, procedimientos y pautas de dosificación para el tratamiento y prevención de síndromes coronarios agudos | |
| AR039378A1 (es) | Preparacion farmaceutica que contiene oxicodona y naloxona | |
| PT2336184E (pt) | Administração de agentes para o tratamento da inflamação | |
| NO20034094L (no) | Sammensetninger som omfatter et antidiar±middel og et epotilon eller et epotilonderivat | |
| CY1112738T1 (el) | Μια συνδυασμενη συνθεση που περιεχει ιβουπροφαινη και παρακεταμολη | |
| IT1302365B1 (it) | Uso di carnitine e resveratrolo per produrre una composizione per laprevenzione o il trattamento terapeutico di alterazioni cerebrali | |
| AR028959A1 (es) | Uso de rapamicina para la manufactura de un medicamento para tratar enfermedades cardiovasculares | |
| PT1185253E (pt) | Forma de administracao oral para administracao de uma combinacao fixa de tramadol e diclofenac | |
| DE50101034D1 (de) | Medizinischer oder dentalmedizinischer behandlungsstuhl | |
| DE60102590D1 (de) | Darreichungsformen zur behandlung von oralen mykosen | |
| AR057643A1 (es) | Lacosamida para terapia adjunta | |
| AR032422A1 (es) | Uso de inhibidores de il-18 para el tratamiento y/o prevencion de la enfermedad cardiaca | |
| UY26171A1 (es) | Método y formulación farmacéutica para el tratamiento de la discinesia de aparición tardía | |
| DE60301862D1 (de) | Kombinationsbehandlung bei akutem myokardinfarkt | |
| CO5210869A1 (es) | Una combinacion sinergetica: gabapentina y pregabalina | |
| AR043327A1 (es) | Uso de inhibidores de quinurenina 3- hidroxilasa para el tratamiento de la diabetes | |
| CO5700723A2 (es) | Uso de un derivado de amina ciclica especifico o de sus sales farmaceuticamente aceptables para tratar y prevenir la insuficiencia cardiaca | |
| BR0108261A (pt) | Uso de mirtazapina, método de tratamento de um distúrbio do sono em um indivìduo, e, kit para paciente para o tratamento de distúrbios do sono | |
| EA200801305A1 (ru) | Применение циклетанина и других фуропиридинов для лечения гипертензии с преобладанием систолического давления, изолированной систолической гипертензии, повышенного пульсового артериального давления и общей гипертензии | |
| AR014082A1 (es) | Concentrado oral de sertralina | |
| AR024981A1 (es) | Composicion para la prevencion y el tratamiento de las disfunciones y enfermedades del rinon | |
| AR039162A1 (es) | Formulaciones de venlafaxina de liberacion extendida | |
| MXPA05009849A (es) | Terapia combinada que comprende nemorubicina y un inhibidor de la ciclooxigenasa-2. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |